Intravenous omega-3, a technique to prevent an excessive innate immune response to cardiac surgery in a rodent gut ischemia model  by Byrne, John et al.
Byrne et al Evolving Technology/Basic ScienceIntravenous omega-3, a technique to prevent an excessive innate
immune response to cardiac surgery in a rodent gut ischemia modelJohn Byrne, MD, Jonathan McGuinness, PhD, Gang Chen, PhD, Arnold D. K. Hill, MD, and











doi:10.1Objectives: Neutrophil infiltration of tissues as part of the inflammatory response to cardiac surgery is one of the
major mediators of postoperative multiple-organ dysfunction. Omega-3 fatty acids markedly attenuate endothe-
lial cell inflammatory responses, including upregulation of neutrophil adhesion molecules. The efficacy of
a clinically safe form of omega-3 to produce this effect in vivo was examined.
Methods: Rat gut intravital microscopic analysis was used to visualize neutrophil transmigration from the micro-
circulation into the tissues of the gut. Inflammatory activation was in the form of 30 minutes of ischemia and 90
minutes of reperfusion. Sham, control (0.9% saline infusion over 4 hours), and omega-3 (Omegaven [Fresenius
Kabi, Bad Homburg, Germany] infusion over 4 hours) pretreatments were compared.
Results: Ischemia–reperfusion resulted in a 4-fold increase in neutrophil adherence to the endothelium (baseline:
4.3  0.2 vs control group: 19.2  3.5 adherent neutrophils per 100 mm, P< .01), which intravenous omega-3
suppressed (7.8 1.7 adherent neutrophils per 100 mm, P<.01). Omega-3 pretreatment also reduced neutrophil
transmigration into the tissues after reperfusion (sham group: 6.3  0.8 vs control group: 13.2  1.4 vs omega-3
group: 9.4  0.9 neutrophils per field, P ¼ .037). Gut tissue levels of the neutrophil-released enzyme myeloper-
oxidase were similarly markedly reduced with omega-3 pretreatment (sham group: 10.5  1.6 vs control group:
19.0  3.3 vs omega-3 group: 10.1  1.2 U/g, P ¼ .03).
Conclusions: Four hours’ pretreatment with a relatively safe form of intravenous omega-3 suppressed neutrophil
adherence and tissue infiltration, resulting in lower levels of the tissue-damaging enzyme myeloperoxidase. This




SIncreasingly, our patients undergoing cardiac surgery are
experiencing multiple-organ dysfunction postoperatively.
This is a result of more limited physiological reserve in adult
patients with the comorbidities of advanced age, diabetes,
hypertension, and diffuse atherosclerosis and also in our pe-
diatric population as a result of more complex procedures at
an earlier age, such as the Norwood procedure, truncus arte-
riosus repair, and arterial switch. A major causative factor of
postoperative multiple-organ dysfunction is excessive acti-
vation of the innate immune response. The innate immune
response is designed to localize a rapid and effective destruc-
tive response to where it is needed in the body. It is nonspe-
cific, being the response to infectious agents, trauma,
ischemia–reperfusion, and the cardiac surgical process.1
The response centers around neutrophils entering the tissues
at the point of injury, whether that be an infected area or ane Department of Surgical Research, the Royal College of Surgeons in Ireland,
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The Journal of Thoracic and Caarea that has undergone ischemic injury, and containment of
the injury locally through release of factors into the tissues to
destroy any infective agent or damaged tissue. Neutrophils
are localized to the point of injury by endothelial cells
producing adhesion molecules on their surface in the micro-
circulation at that point to sequester circulating neutrophils
as they pass. Unfortunately, the cardiac surgical process
produces a systemic inflammatory response, activating this
process in the microcirculation of multiple organs. This is
inadvertent excessive activation of the innate immune
response, which is one of the factors leading to inadvertent
multiple-organ injury.2 This is most easily demonstrated in
the lungs, where there is a positive correlation between
plasma levels of the neutrophil enzyme elastase and respira-
tory dysfunction,3 and inhibition with the experimental drug
ulinastatin (which prevents neutrophil degranulation) can at-
tenuate this injury in animal studies but is unapproved for
human use.4 Similar benefits are seen with leukocyte deple-
tion with an arterial filter with bypass5 but diminish once the
filter is removed. In the heart plasma levels of the neutrophil-
recruiting cytokine interleukin 6 (IL-6) have been correlated
with postoperative myocardial ischemic episodes and echo-
cardiographic wall motion abnormalities in adults,6 and
a recent study in a neonatal population demonstrated that
the IL-6 level 4 hours postoperatively was an independent
risk factor for myocardial dysfunction.7rdiovascular Surgery c Volume 141, Number 3 803
Abbreviation and Acronym
IL-6 ¼ interleukin 6




SPure forms of omega-3 fatty acids have been shown to
attenuate inflammatory activation of endothelial cells.8,9
We have previously shown that exposure of human
endothelial cells in vitro to a clinically useful form of
omega-3 fatty acids for 4 hours can markedly blunt subse-
quent inflammatory activation of the endothelium. We
have demonstrated that through reducing activation of the
inflammatory transcription factor nuclear factor kB, the
omega-3 pretreatment reduced endothelial expression of
adhesion molecules for neutrophils and release of IL-6.10
A previous study in mice has shown that intravenous admin-
istration of the pure oxidized omega-3 fatty acid eicosapen-
taenoic acid can reduce neutrophil adherence to the gut
endothelium in response to inflammatory stimulation with li-
popolysaccharide.11 The objective of this study was to ex-
amine whether a form of intravenous omega-3 fatty acids
that is already in safe clinical use could produce similar
effects on the innate immune response.We also sought to as-
sess whether these effects extended beyond just inhibiting
neutrophil adherence to the endothelium, to migration into
the tissues and prevention of release of damaging factors,
such as myeloperoxidase, into the tissues.
MATERIALS AND METHODS
We used the technique of intravital microscopy to directly visualize the
microcirculation and to characterize the changes in neutrophil adhesion to
the endothelium and tissue transmigration of neutrophils after gut ische-
mia–reperfusion. All experiments were conducted under license from the
Department of Health in Ireland in accordance with national guidelines
for the care of laboratory animals. All experiments were approved by the
ethics committee of the Royal College of Surgeons in Ireland.
Eighteen male Sprague–Dawley rats weighing between 150 and 250 g
were used. After achievement of anesthesia with inhalational 2% isoflurane
(Forane; Abbott Laboratories, Dublin, Ireland) followed by an intraperito-
neal injection of 50 mg/kg sodium pentobarbital (Dolethal; Ve´toquinol,
Lure, France), a tracheostomy was performed to facilitate breathing, and
the left internal jugular vein was cannulated for administration of the control
or treatment infusions. A midline laparotomy was performed. The superior
mesenteric and coeliac vascular pedicles were isolated at their origin and
ensnared. This snare was later tightened to produce ischemia. A segment
of gut and its mesentery was exteriorized through the abdominal wall and
continuously superfused with bicarbonate buffered saline (containing
131.9 mmol/L NaCl, 4.7 mmol/L KCl, 2.0 mmol/L CaCl2, 1.2 mmol/L
MgSO4, and 20 mmol/L NaHCO3 in distilled water, pH 7.4; temperature,
36.5C–37C). An inverted microscope with a 403 objective lens (Nikon
Diaphot 300, Tokyo, Japan) was used to observe the mesenteric microcircu-
lation, and the images were recorded for later offline analysis.
A single unbranched venule with a diameter of 25 to 35 mm and a length
of greater than 100 mm was chosen for observation. After a 10-minute
period of baseline observation, the venular diameter was measured online
with a video caliper (Microcirculation Research Institute, Texas A&M
University, College Station, Tex), and red cell velocity was measured
with an optical Doppler velocimeter (Microvessel Optical Doppler Real-804 The Journal of Thoracic and Cardiovascular SurgTime; CircuSoft Instrumentation, Hockessin, Del). The snare was then
tightened, and the superior mesenteric and coeliac vascular pedicles were
occluded. This was confirmed by occlusion of flow in the observed venule.
After 30 minutes of ischemia, the snare was released, and flow recom-
menced. After re-establishment of flow, the vessel was observed during
reperfusion, with measurement of venular diameter and centerline red cell
velocity. The following parameters were measured at baseline and 60 min-
utes of reperfusion: venular diameter in micrometers, red blood cell center-
line velocity, mean red blood cell velocity, venular wall shear rate, venular
blood flow, leukocyte rolling velocity, leukocyte adherence to the vessel
wall, and leukocyte transmigration.
The experiment was terminated at 90 minutes of reperfusion, and the an-
imals were killed with intravenous sodium pentobarbital. Samples of the gut
were obtained and stored at80C for later determination of tissue myelo-
peroxidase levels. Three experimental groups were used. A sham group
(n ¼ 6) received 5 mL/kg body weight of 0.9% saline (Baxter, Newbury,
United Kingdom) as an infusion over 4 hours before intravital microscopy,
with no ischemia–reperfusion performed in this group. This group served to
demonstrate that the surgical procedure itself did not induce a significant in-
flammatory response. A control group (n ¼ 6) received the same infusion
but underwent 30 minutes of ischemia followed by 90 minutes of reperfu-
sion. An omega-3 group (n ¼ 6) received 5 mL/kg body weight of an
omega-3 fatty acid infusion (Omegaven; Fresenius Kabi, Bad Homburg,
Germany) over 4 hours before ischemia–reperfusion. The recommended
dose for clinical use is 2 mL/kg body weight per day; however, we used
2.5 times this dose because of the higher metabolic rates in small animals.
The infusionwas administered over 4 hours as per the manufacturer’s guide-
lines and administered as a single preoperative dose based on the observa-
tion from our previous in vitro work.10
At baseline, there was no significant difference in the mean red cell ve-
locity between the sham, control, and omega-3–pretreated group, which sig-
nified that the infusions themselves did not have a significant effect on mean
red cell velocity over time. At 60 minutes of reperfusion, there was no dif-
ference in red cell velocity between the omega-3 and control groups
(P ¼ .78), allowing neutrophil measurements to be directly compared.
Venular wall shear rate was also calculated as follows: (Shear
rate¼ (Vmean/Venular diameter)3 8(seconds1).12 This was because differ-
ences between groups might account for differences in neutrophil adherence
and velocity. There was no significant difference in the venular wall shear
rate at baseline among the sham, control, and omega-3–pretreated groups
(P ¼ .9). After ischemia–reperfusion, omega-3 pretreatment did not have
a significant effect on shear rate comparedwith the that seen in control group
(P¼ .971). Again, this rules out any confounding flow-related variables for
our neutrophil measurements between groups.
The frozen gut tissue samples were freeze-thawed, homogenized, and
centrifuged at 2000 rpm for 10 minutes at 4C. The supernatants were
then assayed photometrically for myeloperoxidase activity. One unit of
myeloperoxidase was defined as that degrading 1 micromole of peroxide
per minute.13
Results are quoted as means standard errors of the mean. For multiple
comparisons between groups, statistical analysis was performed with 1-way
analysis of variance. Where significance was observed, the Tukey test was
performed to calculate 95% confidence intervals and identify individual
differences. Comparisons between baseline and 60 minutes of reperfusion
within a single group were performed with the paired sample t test. All
statistical analysis was performed with SPSS software version 15.0
(SPSS, Inc, Chicago, Ill).RESULTS
At baseline, there was no significant difference in the
neutrophil rolling velocity among the sham group (rolling
velocity, 65.1  4.3 mm/s), the control group (56.6 
3.5 mm/s, P ¼ .2), and the omega-3–pretreated groupery c March 2011
FIGURE 1. Leukocyte rolling velocity was measured at baseline and 60
minutes of reperfusion. The normal reduction with activation of the innate
immune response occurred in the control group but was markedly reduced
in the omega-3–pretreated group.
FIGURE 2. The number of leukocytes adherent to the endothelium was
measured at baseline and 60 minutes of reperfusion. It was increased in
the control group as part of the normal innate immune response, but very
little adhesion occurred in the omega-3–pretreated group.




S(52.4 1.5 mm/s, P¼ .7). In the sham group neutrophil roll-
ing velocity at 60 minutes of sham reperfusion (66.7  4.0
mm/s) was not significantly different from the baseline value
(65 4.3 mm/s, P¼ .7); that is, the surgical procedure alone
had no effect on neutrophil rolling velocity over time. At 60
minutes of reperfusion, neutrophil rolling velocity was sig-
nificantly reduced in the control group (33.6  3.2 mm/s)
compared with the baseline value (56.6  3.5 mm/s,
P ¼ .002). In the omega-3–pretreated group neutrophil roll-
ing velocity at 60 minutes of reperfusion (50.1  3.6 mm/s)
was not significantly different from the baseline value
(52.4 1.5 mm/s, P¼ .4); that is, omega-3 pretreatment pre-
vented neutrophil rolling on the endothelium (Figure 1).
With neutrophil adhesion to the endothelium, at baseline
there was no significant difference among the sham, control,
and omega-3–pretreated groups (P ¼ .9). At 60 minutes of
reperfusion, neutrophil adhesion in the control group
(19.2  3.5 adherent neutrophils per 100 mm) was signifi-
cantly increased compared with the baseline value (4.3 
0.2 adherent neutrophils per 100 mm, P ¼ .008). However,
there was much less adherence in the omega-3–pretreated
group (7.83  1.66 adherent neutrophils per 100 mm) com-
pared with that seen in the control group (P ¼ .008). In ad-
dition, the number of adherent neutrophils at 60 minutes in
the omega-3–pretreated group was not significantly different
from that seen in the sham group (P¼ .632, Figures 2 and 3).
Finally, neutrophil transmigration across the endothelium
into the tissues was assessed. At baseline, there were no dif-
ferences in the number of transmigrated neutrophils between
the control and omega-3–pretreated groups (4.7  0.3 vs
4.7  0.3 neutrophils per field, respectively; P ¼ 1.0). At
60 minutes of reperfusion, the number of transmigrated neu-
trophils in the control group (13.2 1.4 neutrophils per field)
was significantly increased compared with the baseline value
(4.7 0.3 neutrophils per field, P¼ .002), as was the case inThe Journal of Thoracic and Cathe omega-3–pretreated group (9.4  0.9 neutrophils per
field, P ¼ .018). However, omega-3 pretreatment signifi-
cantly attenuated the transmigration of neutrophils compared
with that seen in control animals (P ¼ .037, Figure 4). Gut
myeloperoxidase levels were measured to confirm the intra-
vital findings of reduced tissue neutrophil infiltration
because myeloperoxidase is released by neutrophils into
the tissues after they transmigrate. The control group had
increased levels of tissue myeloperoxidase after ischemia–
reperfusion compared with those seen in the sham group
(19.0  3.3 U/g in the control group vs 10.5  1.6 U/g,
P ¼ .04). Omega-3 pretreatment prevented the increase in
tissue myeloperoxidase levels (10.1  1.2 U/g in the
omega-3 group, P ¼ .031, Figure 5).
DISCUSSION
Neutrophil–endothelial interactions are early and critical
events in patients with acute inflammation.14 Neutrophils
are normally targeted to sites of tissue damage and anchored
through the expression of cell adhesion molecules. Dysregu-
lation of this process results in excessive and inappropriate
extravasation of leukocytes. These activated neutrophils re-
lease reactive oxygen species and other toxic enzymes, such
as elastase, myeloperoxidase, hydrolase, and collagenases.
Excessive production of these results in organ injury and
is found in hyperinflammatory states associated with critical
illness and multiple-organ dysfunction syndrome.15
Neutrophil activation occurs after cardiopulmonary
bypass because of many factors, including contact with the
extracorporeal circuit and activated platelets, although acti-
vated complement components formed after contact activa-
tion are probably the main activators of neutrophils.16 The
technique of intravital microscopy has been used widely to
characterize the sequence of events that leads to the eventual
transmigration of leukocytes into the tissue spaces as a resultrdiovascular Surgery c Volume 141, Number 3 805
FIGURE 3. Images from intravital microscopy at 60 minutes of reperfusion. A mesenteric venule is shown in the center with multiple adherent leukocytes in
the control group and very few in the omega-3–pretreated group.




Sof a multitude of inflammatory insults. In the postcapillary
venule margination of leukocytes to the periphery occurs
as a result of hemodynamic forces. This is followed by roll-
ing of the leukocyte along the endothelium, firm adhesion,
and then transmigration or diapedesis of the leukocyte into
the tissue spaces.17 In this study we observed that gut ische-
mia–reperfusion injury resulted in a significant reduction in
mean red cell velocity, reduced mesenteric blood flow, and
reduced venular wall shear rate. This was associated with
a reduction in the velocity of leukocytes rolling along the en-
dothelium, increased adhesion of leukocytes to the endothe-
lium, and increased transmigration of leukocytes into the
tissue spaces. This indicates upregulation of cell adhesion
molecules, causing the increased leukocyte–endothelial in-
teractions we observed.12 Myeloperoxidase is a neutrophil
enzyme, and measurements of increased tissue levels ofFIGURE 4. The number of leukocytes present in the extravascular tissues
having traversed the endothelium of the venule were counted at baseline and
60 minutes of reperfusion. Omega-3 pretreatment attenuated the normal re-
sponse of leukosequestration in the tissues.
806 The Journal of Thoracic and Cardiovascular Surgmyeloperoxidase reflect leukocyte infiltration into the tis-
sues.18 Pretreatment with a clinically relevant omega-3 infu-
sion did not have a significant effect on baseline mean red
cell velocity, blood flow, or venular wall shear rate. There
was no effect on baseline adhesion or transmigration of
leukocytes. After gut ischemia–reperfusion, mean red cell
velocity, blood flow, and venular wall shear were signifi-
cantly reduced in the omega-3–pretreated group, which is
similar to what was seen in the control group. Omega-3
did not have a significant effect on the reduction in these pa-
rameters because of ischemia–reperfusion compared with
the control group. We know that vessel wall shear affects
leukocyte adherence to the endothelium.12 Thus our obser-
vation of equal hemodynamic changes in the control and
omega-3–pretreated groups after ischemia–reperfusion is
important. We can safely infer that any observed beneficialFIGURE 5. Gut myeloperoxidase levels were measured from homoge-
nized tissue after 90 minutes of reperfusion. Myeloperoxidase is released
from activated neutrophils in the tissues and was found to be reduced in
the omega-3–pretreated group compared with the control group, confirming
our findings of reduced transmigration on intravital microscopy.
ery c March 2011




Seffect of omega-3 pretreatment to attenuate the upregulation
of leukocyte–endothelial interactions caused by ischemia–
reperfusion is due to a difference in cell adhesion molecule
expression and not due to effects on microcirculatory hemo-
dynamics.
Pretreatment with omega-3 significantly attenuated the
reduction in leukocyte rolling velocity, reduced the number
of leukocytes firmly adherent to the endothelium, and re-
duced the number of transmigrated leukocytes occurring
as a result of gut ischemia–reperfusion injury compared
with the control group. The reduced transmigration of leuko-
cytes was directly observed by using intravital microscopy
and also demonstrated by the reduced gut myeloperoxidase
levels seen in animals pretreated with omega-3.
These findings are consistent with previous in vitro work
assessing the effect of pure forms of omega-3 on endothelial
cell adhesion molecule expression8 and monocyte adhesion
to endothelial cells in culture8,9 and in a murine intravital
microscopic model in which leukocyte rolling and
adhesion to the venular endothelium in response to
systemic lipopolysaccharide was reduced.11 However, these
pure forms of omega-3 could never be administered safely in
their current forms to human subjects. We have worked with
a clinically safe form of omega-3 and have demonstrated that
it has similar anti-inflammatory effects in vitro on endothe-
lial cells to pure forms.10 We have also shown that it medi-
ates its effects through inhibition of the acute inflammatory
transcription factor nuclear factor kB and has minimal ef-
fects on the neutrophil and that its effects on the endothelium
are reversible within 48 hours.10 This omega-3 formulation
was originally designed as a lipid component of parenteral
nutrition and has an established safety profile.9,19 In this
study we used a higher dose of the omega-3 infusion that
is used currently clinically. This was because we believed
that with the rat’s higher metabolic rate, they would need
a higher dose to have a bioequivalent effect to that seen in
human subjects. We believe that in human subjects the nor-
mal maximum recommended dose would be sufficient to in-
duce the anti-inflammatory effect because a previous study
in healthy volunteers using the omega-3 infusion for 4 hours
on 2 days resulted in reduced activated monocyte cytokine
production.9 However, if the infusion was to be used at
higher doses, then the potential adverse effects to look for
would be hyperglycemia, metabolic acidosis, and bleeding
tendency caused by abnormal platelet function.
It appears from this study that a single dose over 4 hours
just before the inflammatory insult has potent effects to
minimize neutrophil–endothelial interactions (ie, the innateThe Journal of Thoracic and Caimmune response). We plan to conduct further studies in
a cardiopulmonary bypass circulatory arrest model to assess
its efficacy in attenuating multiple-organ dysfunction.
A single preoperative intravenous dose of omega-3 might
be a simple addition to our current strategies to optimize
recovery after cardiac surgery.References
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